Literature DB >> 12795059

Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment.

Jae-Won Soh1, I Bernard Weinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12795059     DOI： 10.1159/000071377

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  18 in total

1.  Indomethacin impairs mitochondrial dynamics by activating the PKCζ-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells.

Authors:  Somnath Mazumder; Rudranil De; Subhashis Debsharma; Samik Bindu; Pallab Maity; Souvik Sarkar; Shubhra Jyoti Saha; Asim Azhar Siddiqui; Chinmoy Banerjee; Shiladitya Nag; Debanjan Saha; Saikat Pramanik; Kalyan Mitra; Uday Bandyopadhyay
Journal:  J Biol Chem       Date:  2019-04-02       Impact factor: 5.157

2.  Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: a preclinical evaluation.

Authors:  Alejandro D Soriano-Hernández; Hector R Galvan-Salazar; Daniel A Montes-Galindo; Alejandrina Rodriguez-Hernandez; Rafael Martinez-Martinez; Jose Guzman-Esquivel; Laura L Valdez-Velazquez; Luz M Baltazar-Rodriguez; Francisco Espinoza-Gómez; Augusto Rojas-Martinez; Rocio Ortiz-Lopez; Rafael Gonzalez-Alvarez; Ivan Delgado-Enciso
Journal:  Int Urol Nephrol       Date:  2011-06-10       Impact factor: 2.370

Review 3.  Systems psychopharmacology: A network approach to developing novel therapies.

Authors:  Peter J Gebicke-Haerter
Journal:  World J Psychiatry       Date:  2016-03-22

4.  The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation.

Authors:  Natassa Pippa; Faidra Psarommati; Stergios Pispas; Costas Demetzos
Journal:  Pharm Res       Date:  2013-06-07       Impact factor: 4.200

5.  Molecular alterations associated with sulindac-resistant colon tumors in ApcMin/+ mice.

Authors:  Emily J Greenspan; Frank C Nichols; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-17

6.  Investigation of the effect of meclofenamic acid on the proteome of LNCaP cells reveals changes in alternative polyadenylation and splicing machinery.

Authors:  Busra Sahinoz Saglam; Aylin Kanli; Sevinc Yanar; Murat Kasap; Gurler Akpinar
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

7.  A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagy.

Authors:  Evrim Gurpinar; William E Grizzle; John J Shacka; Burton J Mader; Nan Li; Nicholas A Piazza; Suzanne Russo; Adam B Keeton; Gary A Piazza
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

8.  Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer.

Authors:  Yoshihiro Watanabe; Yorihisa Imanishi; Hiroyuki Ozawa; Koji Sakamoto; Ryoichi Fujii; Seiji Shigetomi; Noboru Habu; Kuninori Otsuka; Yoichiro Sato; Mariko Sekimizu; Fumihiro Ito; Yuichi Ikari; Shin Saito; Kaori Kameyama; Kaoru Ogawa
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

9.  Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations.

Authors:  Svenja D Steinbrink; Carlo Pergola; Ulrike Bühring; Sven George; Julia Metzner; Astrid S Fischer; Ann-Kathrin Häfner; Joanna M Wisniewska; Gerd Geisslinger; Oliver Werz; Dieter Steinhilber; Thorsten J Maier
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

10.  The nonsteroidal anti-inflammatory drug indomethacin induces heterogeneity in lipid membranes: potential implication for its diverse biological action.

Authors:  Yong Zhou; John F Hancock; Lenard M Lichtenberger
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.